stockrowPediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
Follow MD
Alert me
Pediatrix Medical Group, Inc. (MD) EPS (diluted)
Pediatrix Medical Group, Inc.'s EPS (diluted) for fiscal 2025 was $1.94, compared with −$1.19 in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.84. Over the past ten years it has ranged from −$17.94 (fiscal 2019) to $3.58 (fiscal 2015); the current reading is higher than 64% of that period. Pediatrix Medical Group, Inc. ranks 13th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $1.94 | — |
| FY2024 | −$1.19 | — |
| FY2023 | −$0.73 | — |
| FY2022 | $0.79 | (48.37%) |
| FY2021 | $1.53 | — |
| FY2020 | −$9.55 | — |
| FY2019 | −$17.94 | — |
| FY2018 | $2.93 | (15.07%) |
| FY2017 | $3.45 | (1.15%) |
| FY2016 | $3.49 | (2.51%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.59 | 20.29% |
| Jun 2026 | $0.49 | 36.11% |
| Mar 2026 | $0.36 | (10.00%) |
| Dec 2025 | $0.40 | (52.38%) |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NHC National HealthCare Corporation compare | $7.24 |
| ADUS Addus HomeCare Corporation compare | $6.00 |
| MD Pediatrix Medical Group, Inc. | $1.84 |
| AVAH Aveanna Healthcare Holdings Inc. compare | $1.23 |
| GRDN Guardian Pharmacy Services, Inc. compare | $1.03 |
| ASTH Astrana Health, Inc. compare | $0.82 |
| BKD Brookdale Senior Living Inc. compare | −$0.58 |
| SGRY Surgery Partners, Inc. compare | −$0.70 |
| ACHC Acadia Healthcare Company, Inc. compare | −$12.47 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on MD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement